You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API paliperidone


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing paliperidone

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Patriot Pharmaceuticals LLC PALIPERIDONE paliperidone 10147-0952 BUTYLATED HYDROXYTOLUENE
Patriot Pharmaceuticals LLC PALIPERIDONE paliperidone 10147-0952 CARNAUBA WAX
Patriot Pharmaceuticals LLC PALIPERIDONE paliperidone 10147-0952 CELLULOSE ACETATE
Patriot Pharmaceuticals LLC PALIPERIDONE paliperidone 10147-0952 FERROSOFERRIC OXIDE
Patriot Pharmaceuticals LLC PALIPERIDONE paliperidone 10147-0952 HYPROMELLOSE
Patriot Pharmaceuticals LLC PALIPERIDONE paliperidone 10147-0952 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing paliperidone

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc paliperidone 0378-3978 BUTYLATED HYDROXYTOLUENE
Mylan Pharmaceuticals Inc paliperidone 0378-3978 CELLULOSE ACETATE
Mylan Pharmaceuticals Inc paliperidone 0378-3978 FERRIC OXIDE RED
Mylan Pharmaceuticals Inc paliperidone 0378-3978 FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc paliperidone 0378-3978 FERROSOFERRIC OXIDE
Mylan Pharmaceuticals Inc paliperidone 0378-3978 HYDROXYPROPYL CELLULOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for paliperidone

Excipient focus: ACETONE

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CARBOMER HOMOPOLYMER TYPE A

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE ACETATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FUMARIC ACID

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSE PHTHALATE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: N-BUTYL ALCOHOL

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 100000

Excipient focus: POLYETHYLENE GLYCOL 1000000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

paliperidone drug variants containing POLYETHYLENE GLYCOL 4000

Company Ingredient NDC
Mylan Pharmaceuticals Inc paliperidone 0378-3978
Mylan Institutional Inc paliperidone 42292-026
Janssen Pharmaceuticals Inc paliperidone palmitate 50458-560
Janssen Pharmaceuticals Inc paliperidone palmitate 50458-606
Janssen Pharmaceuticals Inc paliperidone palmitate 50458-611
Shandong Luye Pharmaceutical Co Ltd paliperidone palmitate 72526-105
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 7000000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYETHYLENE OXIDE 200000

Excipient focus: POLYETHYLENE OXIDE 5000000

Excipient focus: POLYETHYLENE OXIDE 7000000

Excipient focus: POLYSORBATE 20

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links